Bioactivation as a model for drug design bioreductive alkylation.
D000475:Alkenes; D000477:Alkylating Agents / Q000378:metabolism; D000588:Amines; D000900:Anti-Bacterial Agents / Q000378:metabolism; D000903:Antibiotics, Antineoplastic / Q000378:metabolism; D001711:Biotransformation; D002166:Camptothecin; D003630:Daunorubicin / Q000378:metabolism; D004317:Doxorubicin / Q000378:metabolism; D007769:Lactams; D007783:Lactones; D008937:Mitomycins / Q000378:metabolism; D008956:Models, Chemical; D011809:Quinones; D013329:Structure-Activity Relationship
D000475:Alkenes; D000477:Alkylating Agents; D000588:Amines; D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D007769:Lactams; D007783:Lactones; D008937:Mitomycins; D011809:Quinones; D004317:Doxorubicin; D002166:Camptothecin; D003630:Daunorubicin